Pyruvate kinase isoenzyme M2 is a therapeutic target of gemcitabine-resistant pancreatic cancer cells.
Kim DJ, Park YS, Kang MG, You YM, Jung Y, Koo H, Kim JA, Kim MJ, Hong SM, Lee KB, Jang JJ, Park KC, Yeom YI.
Kim DJ, et al. Among authors: kang mg.
Exp Cell Res. 2015 Aug 1;336(1):119-29. doi: 10.1016/j.yexcr.2015.05.017. Epub 2015 Jun 22.
Exp Cell Res. 2015.
PMID: 26112218